
|Articles|December 13, 2007
Trilostane: A new treatment option for dogs with hyperadrenocorticism (1:40)
Author(s)David S. Bruyette, DVM, DACVIM
"The advantage of trilostane seems to be a much higher safety profile than Lysodren with an equal efficacy rate."
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on dvm360
1
USDA approves canine vaccination for Lyme disease and leptospirosis
2
Weekly Vet Report: First clinical use of TMJ arthroscopy in dogs, Lyme-lepto combo vaccine approval, & more
3
Survey highlights gaps in canine pruritus management expectations
4
Veterinary hospice offers cats and clients familiar comforts (Part 1): Familiarize clients with veterinary hospice
5









